Cargando…
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
Patients with the 15q11.2 BP1–BP2 microdeletion can present with developmental and language delay, neurobehavioral disturbances and psychiatric problems. Autism, seizures, schizophrenia and mild dysmorphic features are less commonly seen. The 15q11.2 BP1–BP2 microdeletion involving four genes (i.e.,...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346944/ https://www.ncbi.nlm.nih.gov/pubmed/25689425 http://dx.doi.org/10.3390/ijms16024068 |
_version_ | 1782359766494871552 |
---|---|
author | Cox, Devin M. Butler, Merlin G. |
author_facet | Cox, Devin M. Butler, Merlin G. |
author_sort | Cox, Devin M. |
collection | PubMed |
description | Patients with the 15q11.2 BP1–BP2 microdeletion can present with developmental and language delay, neurobehavioral disturbances and psychiatric problems. Autism, seizures, schizophrenia and mild dysmorphic features are less commonly seen. The 15q11.2 BP1–BP2 microdeletion involving four genes (i.e., TUBGCP5, CYFIP1, NIPA1, NIPA2) is emerging as a recognized syndrome with a prevalence ranging from 0.57%–1.27% of patients presenting for microarray analysis which is a two to four fold increase compared with controls. Review of clinical features from about 200 individuals were grouped into five categories and included developmental (73%) and speech (67%) delays; dysmorphic ears (46%) and palatal anomalies (46%); writing (60%) and reading (57%) difficulties, memory problems (60%) and verbal IQ scores ≤75 (50%); general behavioral problems, unspecified (55%) and abnormal brain imaging (43%). Other clinical features noted but not considered as common were seizures/epilepsy (26%), autism spectrum disorder (27%), attention deficit disorder (ADD)/attention deficit hyperactivity disorder (ADHD) (35%), schizophrenia/paranoid psychosis (20%) and motor delay (42%). Not all individuals with the deletion are clinically affected, yet the collection of findings appear to share biological pathways and presumed genetic mechanisms. Neuropsychiatric and behavior disturbances and mild dysmorphic features are associated with genomic imbalances of the 15q11.2 BP1–BP2 region, including microdeletions, but with an apparent incomplete penetrance and variable expressivity. |
format | Online Article Text |
id | pubmed-4346944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-43469442015-04-03 The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review Cox, Devin M. Butler, Merlin G. Int J Mol Sci Review Patients with the 15q11.2 BP1–BP2 microdeletion can present with developmental and language delay, neurobehavioral disturbances and psychiatric problems. Autism, seizures, schizophrenia and mild dysmorphic features are less commonly seen. The 15q11.2 BP1–BP2 microdeletion involving four genes (i.e., TUBGCP5, CYFIP1, NIPA1, NIPA2) is emerging as a recognized syndrome with a prevalence ranging from 0.57%–1.27% of patients presenting for microarray analysis which is a two to four fold increase compared with controls. Review of clinical features from about 200 individuals were grouped into five categories and included developmental (73%) and speech (67%) delays; dysmorphic ears (46%) and palatal anomalies (46%); writing (60%) and reading (57%) difficulties, memory problems (60%) and verbal IQ scores ≤75 (50%); general behavioral problems, unspecified (55%) and abnormal brain imaging (43%). Other clinical features noted but not considered as common were seizures/epilepsy (26%), autism spectrum disorder (27%), attention deficit disorder (ADD)/attention deficit hyperactivity disorder (ADHD) (35%), schizophrenia/paranoid psychosis (20%) and motor delay (42%). Not all individuals with the deletion are clinically affected, yet the collection of findings appear to share biological pathways and presumed genetic mechanisms. Neuropsychiatric and behavior disturbances and mild dysmorphic features are associated with genomic imbalances of the 15q11.2 BP1–BP2 region, including microdeletions, but with an apparent incomplete penetrance and variable expressivity. MDPI 2015-02-13 /pmc/articles/PMC4346944/ /pubmed/25689425 http://dx.doi.org/10.3390/ijms16024068 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cox, Devin M. Butler, Merlin G. The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title | The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_full | The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_fullStr | The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_full_unstemmed | The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_short | The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_sort | 15q11.2 bp1–bp2 microdeletion syndrome: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346944/ https://www.ncbi.nlm.nih.gov/pubmed/25689425 http://dx.doi.org/10.3390/ijms16024068 |
work_keys_str_mv | AT coxdevinm the15q112bp1bp2microdeletionsyndromeareview AT butlermerling the15q112bp1bp2microdeletionsyndromeareview AT coxdevinm 15q112bp1bp2microdeletionsyndromeareview AT butlermerling 15q112bp1bp2microdeletionsyndromeareview |